R-minichop
R-minichop has been studied in 2 papers since 2021: 2 observational studies in people. The newest paper, Jun 26, 2023: “Treatment Individualization in Diffuse Large B-Cell Lymphoma: Is Frailty Enough for Old Adults? An Original Article”.
2 papers study itUpdated
See all 2 papers on r-minichop
At a glance
1 trial, none about aging.
Cells, worms or flies, mice and humans: nothing yet.
- 1 trial, none about aging
- Humans2
Trial sponsors
Company1 trialPhase 1/2543 people
Latest
Clinical Lymphoma, Myeloma & Leukemia
Treatment Individualization in Diffuse Large B-Cell Lymphoma: Is Frailty Enough for Old Adults? An Original Article
Study of 31 peopleFrailty
Blood Advances
A simplified frailty score predicts survival and can aid treatment-intensity decisions in older patients with DLBCL
Cohort study of 784 peopleBiomarkers